Adagio Medical (NASDAQ:ADGM – Get Free Report) and Beauty Health (NASDAQ:SKIN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.
Analyst Recommendations
This is a summary of recent ratings and price targets for Adagio Medical and Beauty Health, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Adagio Medical | 0 | 0 | 0 | 0 | 0.00 |
| Beauty Health | 1 | 3 | 1 | 0 | 2.00 |
Beauty Health has a consensus price target of $2.55, indicating a potential upside of 54.55%. Given Beauty Health’s stronger consensus rating and higher possible upside, analysts clearly believe Beauty Health is more favorable than Adagio Medical.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Adagio Medical | N/A | 160.59% | 40.99% |
| Beauty Health | -8.11% | -44.83% | -3.54% |
Risk and Volatility
Adagio Medical has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500.
Valuation and Earnings
This table compares Adagio Medical and Beauty Health”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Adagio Medical | N/A | N/A | -$2.13 million | N/A | N/A |
| Beauty Health | $347.62 million | 0.59 | -$100.12 million | ($0.42) | -3.93 |
Adagio Medical has higher earnings, but lower revenue than Beauty Health.
Insider & Institutional Ownership
48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 53.5% of Adagio Medical shares are held by insiders. Comparatively, 41.0% of Beauty Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Beauty Health beats Adagio Medical on 6 of the 11 factors compared between the two stocks.
About Adagio Medical
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Receive News & Ratings for Adagio Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adagio Medical and related companies with MarketBeat.com's FREE daily email newsletter.
